SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-181069
Filing Date
2020-06-26
Accepted
2020-06-26 16:51:05
Documents
5
Period of Report
2020-08-12
Effectiveness Date
2020-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d944412ddef14a.htm DEF 14A 1341916
2 GRAPHIC g944412dsp001c.jpg GRAPHIC 832
3 GRAPHIC g944412dsp001gif.jpg GRAPHIC 2291
4 GRAPHIC g944412g09u54.jpg GRAPHIC 55675
5 GRAPHIC g944412g65t06.jpg GRAPHIC 27367
  Complete submission text file 0001193125-20-181069.txt   1462432
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 20994711
SIC: 2834 Pharmaceutical Preparations